Sodium pentaborate for mild to moderate Alzheimer's disease
Part of Brain & nervous system, Mental health clinical trials.
This trial tests whether a daily oral treatment, sodium pentaborate, is safe and helps memory in people with mild to moderate Alzheimer's disease. If you are on stable Alzheimer's medication and have no other major brain conditions, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 55 and 85 years old
- Have a diagnosis of mild to moderate Alzheimer's disease (confirmed by a doctor)
- Have some memory problems (episodic memory impairment)
- Be on a stable dose of Alzheimer's medications (e.g., donepezil, memantine)
- No other major brain or psychiatric disorders (like schizophrenia or major depression)
- No signs of brain swelling or bleeding (ARIA) on an MRI, and no recent use of experimental drugs
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a supplement called 2-HOBA in people with mild memory problems or early Alzheimer's. It may help protect brain cells and slow down memory decline.
This Phase 2 trial tests an oral medicine (EX039) to see if it can help people with mild Alzheimer’s disease. It focuses on slowing or improving thinking and memory problems over time.
This study tests whether a water pill called bumetanide can help people with early Alzheimer's disease. It involves taking the study drug, having MRI scans, and doing memory tests to see if it slows down symptoms.
This study tests a new drug (BnH-015B) for people with moderate Alzheimer's disease. It also includes a small group of healthy young men for comparison. The goal is to see if the drug is safe and how it works in the body.
This trial tests a drug called masitinib to see if it can help people with mild Alzheimer's disease. You'd get either the drug or a placebo, and doctors will check if your daily living skills and memory slow their decline.
This study tests a sequence of treatments to see if they can help people with Alzheimer's disease or mild cognitive impairment. It aims to slow down memory decline and improve daily function.
Hear when a new Alzheimer Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.